ArticlePharmaceuticals (Basel, Switzerland)2024

Computational Design of Novel Tau-Tubulin Kinase 1 Inhibitors for Neurodegenerative Diseases.

Shahzaib Ahamad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.